Oppenheimer analyst Christopher Glynn lowered his price target for Acuity Brands to $145 from $150, while reiterating an Outperform rating on the shares following quarterly results. The analyst notes that margin indices continue to show favorable traction, as Acuity Brands likely has weathered greatest severity of mix and low-end competition impacts over recent years and is pruning low/no margin sales. GM should be up again sequentially in Q4, he contends, adding that he expects 3% 2020 top line, which should establish a favorable backdrop to show margin benefits from strategic actions.